Chloride intracellular channel 1 cooperates with potassium channel EAG2 to promote medulloblastoma growth

Michelle A Francisco1,2, Siyi Wanggou1,2,3,4, Jerry J Fan1,2,5

  • 1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Insights

Chloride intracellular channel 1 (CLIC1) is overexpressed in pediatric brain tumors. Targeting CLIC1 and EAG2 channels suppresses medulloblastoma growth by regulating cell volume and proliferation.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Ion channel research

Background:

  • Ion channels are crucial drug targets, yet their function in brain cancers remains largely unknown.
  • Chloride intracellular channel 1 (CLIC1) is identified as overexpressed in central nervous system malignancies, particularly medulloblastoma.

Purpose of the Study:

  • To investigate the role of CLIC1 in medulloblastoma development and tumorigenesis.
  • To elucidate the molecular mechanisms underlying CLIC1's function in cancer cells.

Main Methods:

  • Utilized genetic deletion of CLIC1 in mouse models (xenograft and genetically engineered).
  • Examined CLIC1 localization during mitosis and its interaction with EAG2 at lipid rafts.
  • Assessed cell volume, RNA biosynthesis, and p38 MAPK pathway activation.
  • Performed concurrent knockdown of CLIC1/EAG2 in human medulloblastoma and Drosophila brain tumor models.

Main Results:

  • Genetic deletion of CLIC1 suppressed medulloblastoma growth in vivo.
  • CLIC1 localizes to the plasma membrane during mitosis, cooperating with EAG2 to maintain cell volume homeostasis.
  • CLIC1 deficiency led to increased cell/nuclear volume ratio, disrupted RNA synthesis-cell size coupling, and activated p38 MAPK, inhibiting proliferation.
  • Simultaneous knockdown of CLIC1 and EAG2 synergistically inhibited tumor growth in both human and Drosophila models.

Conclusions:

  • CLIC1 is a key molecular dependency in rapidly proliferating medulloblastoma cells.
  • CLIC1 regulates tumorigenesis through cell volume control and pathway modulation.
  • Targeting CLIC1 and its partner EAG2 presents a potential therapeutic strategy for medulloblastoma.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
10.0K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
544
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.6K
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
1.8K
Ion Channels01:19

Ion Channels

The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
90.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
741